Sunitinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Sunitinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Sunitinib included in the composition |
Prices in pharmacies |
| Sunitinib | — |
| Sunitinib-nativ | 48€ |
| Sutent | 48.5-338.1€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 58% Cabozantinib
- 58% Pazopanib
- 56% Erlotinib
- 53% Axitinib
- 53% Regorafenib
- 49% Encorafenib
- 48% Sorafenib
- 43% Nintedanib
- 41% Abemaciclib
- 39% Trametinib
- 39% Lorlatinib
- 39% Selpercatinib
- 37% Alectinib
- 37% Zanubrutinib
- 37% Palbociclib
- 36% Ibrutinib
- 33% Irinotecan
- 33% Nivolumab
- 33% Dasatinib
- 32% Imatinib
- 32% Binimetinib
- 32% Vandetanib
- 32% Capivasertib
- 30% Ribociklib
- 30% Ceritinib
- 30% Osimertinib
- 30% Afatinib
- 30% Capmatinib
- 30% Akalabrutinib
- 28% Bosutinib
- 27% Dipin
- 27% Panitumumab
- 26% Ramucirumab
- 25% Oxaliplatin
- 25% Folinic acid
- 25% Ruxolitinib
- 25% Fedratinib
- 24% Larotrectinib
- 24% Pentagastrin
- 24% Gemcitabine
- 24% Lapatinib
- 24% Nilotinib
- 24% Cobimetinib
- 24% Dabrafenib
- 24% Vemurafenib
- 23% Inonotus Obliquus
- 23% Cetuximab
- 23% Camrelizumab
- 22% Capecitabine
- 22% Crizotinib
Learn more about the selection of analogues
▶
- The drug has «Sunitinib» 51 analog by action, the most similar - Cabozantinib .
- Medical online service has selected the best substitutes for Sunitinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Sunitinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.